Literature DB >> 24197803

Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis.

Pierpaolo Trimboli1, Giorgio Treglia, Leo Guidobaldi, Enrico Saggiorato, Giuseppe Nigri, Anna Crescenzi, Francesco Romanelli, Fabio Orlandi, Stefano Valabrega, Ramin Sadeghi, Luca Giovanella.   

Abstract

Indeterminate thyroid nodules (ITN) constitute the gray zone of thyroid fine-needle aspiration cytology (FNAC). About 70-80 % of ITN are later diagnosed as benign; therefore, it is very important to identify the predictors of malignancy. Aim of the study was to summarize published data about clinical risk factors for malignancy in patients with ITN and thereby provide more robust estimates of the effect of these risk factors. Sources comprised studies published through December 2012. Original articles that investigated clinical parameters as potential predictors of malignancy in ITN were identified. Two authors performed the data extraction independently. A meta-analysis of 19 relevant studies was conducted that included 3,494 patients with ITN according to FNAC. The pooled prevalence of malignancy was 28 % (95 % CI 23-33), 26 % in females and 34 % in males. The pooled OR was 1.51 (95 % CI 1.2-1.83) for males and 0.68 (95 % CI 0.53-0.88) for females. Regarding the nodule's size, the pooled OR was 2.10 (95 % CI 1.26-3.50) for nodules >4 cm in diameter. Analysis of the patient age as a risk factor was not feasible because of marked difference found between the studies. In patients with indeterminate thyroid nodules diagnosed at FNAC, the pooled rate of malignancy from 19 studies was 28 %. Patients that are male and have ITN greater than 4 cm in diameter should be considered at higher risk of cancer.

Entities:  

Mesh:

Year:  2013        PMID: 24197803     DOI: 10.1007/s12020-013-0057-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  48 in total

1.  Can cytology accurately predict benign follicular nodules?

Authors:  Jenni Smith; Rona E Cheifetz; Nathan Schneidereit; Kenneth Berean; Tom Thomson
Journal:  Am J Surg       Date:  2005-05       Impact factor: 2.565

Review 2.  Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm.

Authors:  Pierpaolo Trimboli; Emma Condorelli; Antonio Catania; Salvatore Sorrenti
Journal:  Diagn Cytopathol       Date:  2009-10       Impact factor: 1.582

3.  Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?

Authors:  Robert T Pu; Jack Yang; Patricia G Wasserman; Tawfiqul Bhuiya; Kent A Griffith; Claire W Michael
Journal:  Diagn Cytopathol       Date:  2006-05       Impact factor: 1.582

4.  Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients.

Authors:  W Raber; K Kaserer; B Niederle; H Vierhapper
Journal:  Thyroid       Date:  2000-08       Impact factor: 6.568

5.  Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features.

Authors:  Nese Ersoz Gulcelik; Mehmet Ali Gulcelik; Bekir Kuru
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-12

6.  Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration.

Authors:  R M Tuttle; H Lemar; H B Burch
Journal:  Thyroid       Date:  1998-05       Impact factor: 6.568

7.  Fine-needle aspiration of thyroid: an institutional experience.

Authors:  Z W Baloch; M J Sack; G H Yu; V A Livolsi; P K Gupta
Journal:  Thyroid       Date:  1998-07       Impact factor: 6.568

8.  Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique.

Authors:  Naim Nasrollah; Pierpaolo Trimboli; Leo Guidobaldi; Davide Domenico Cicciarella Modica; Claudio Ventura; Giovanni Ramacciato; Silvia Taccogna; Francesco Romanelli; Stefano Valabrega; Anna Crescenzi
Journal:  Endocrine       Date:  2012-10-16       Impact factor: 3.633

9.  Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.

Authors:  Ying Y Liu; Hans Morreau; Job Kievit; Johannes A Romijn; Nancy Carrasco; Johannes W Smit
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

10.  Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Authors:  Armando Bartolazzi; Fabio Orlandi; Enrico Saggiorato; Marco Volante; Federico Arecco; Ruth Rossetto; Nicola Palestini; Ezio Ghigo; Mauro Papotti; Gianni Bussolati; Marco Paolo Martegani; Federico Pantellini; Angelo Carpi; Maria Rosaria Giovagnoli; Salvatore Monti; Vincenzo Toscano; Salvatore Sciacchitano; Gian Maria Pennelli; Caterina Mian; Maria Rosa Pelizzo; Massimo Rugge; Giancarlo Troncone; Lucio Palombini; Gennaro Chiappetta; Gerardo Botti; Aldo Vecchione; Rino Bellocco
Journal:  Lancet Oncol       Date:  2008-05-19       Impact factor: 41.316

View more
  23 in total

1.  A cost analysis of thyroid core needle biopsy vs. diagnostic surgery.

Authors:  Pierpaolo Trimboli; Naim Nasrollah; Stefano Amendola; Anna Crescenzi; Leo Guidobaldi; Carlo Chiesa; Riccardo Maglio; Giuseppe Nigri; Alfredo Pontecorvi; Francesco Romanelli; Laura Giacomelli; Stefano Valabrega
Journal:  Gland Surg       Date:  2015-08

2.  The role of qualitative elastography in thyroid nodule evaluation: exploring its target populations.

Authors:  Jakob W Kist; Sjoerd Nell; Bart de Keizer; Gerlof D Valk; Inne H M Borel Rinkes; Menno R Vriens
Journal:  Endocrine       Date:  2015-06-10       Impact factor: 3.633

3.  Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules.

Authors:  Pierpaolo Trimboli; Leo Guidobaldi; Stefano Amendola; Naim Nasrollah; Francesco Romanelli; Daniela Attanasio; Giovanni Ramacciato; Enrico Saggiorato; Stefano Valabrega; Anna Crescenzi
Journal:  Endocrine       Date:  2015-07-04       Impact factor: 3.633

4.  Thyroid core needle biopsy: taking stock of the situation.

Authors:  Pierpaolo Trimboli; Anna Crescenzi
Journal:  Endocrine       Date:  2014-08-17       Impact factor: 3.633

5.  Diagnostic performance of elastography in cytologically indeterminate thyroid nodules.

Authors:  Francesca Garino; Maurilio Deandrea; Manuela Motta; Alberto Mormile; Federico Ragazzoni; Nicola Palestini; Milena Freddi; Guido Gasparri; Enrico Sgotto; Donatella Pacchioni; Paolo Piero Limone
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

Review 6.  Performance of Italian Consensus for the Classification and Reporting of Thyroid Cytology (ICCRTC) in discriminating indeterminate lesions at low and high risk of malignancy. A systematic review and meta-analysis.

Authors:  Pierpaolo Trimboli; Anna Crescenzi; Luca Giovanella
Journal:  Endocrine       Date:  2017-08-07       Impact factor: 3.633

7.  Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.

Authors:  Yong Joon Suh; Yeon Ju Choi
Journal:  Endocrine       Date:  2020-04-15       Impact factor: 3.633

8.  Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.

Authors:  Pablo Valderrabano; Laila Khazai; Zachary J Thompson; Kristen J Otto; Julie E Hallanger-Johnson; Christine H Chung; Barbara A Centeno; Bryan McIver
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-09-01       Impact factor: 6.223

9.  Reliability of real-time elastography to diagnose thyroid nodules previously read at FNAC as indeterminate: a meta-analysis.

Authors:  Pierpaolo Trimboli; Giorgio Treglia; Ramin Sadeghi; Francesco Romanelli; Luca Giovanella
Journal:  Endocrine       Date:  2014-12-23       Impact factor: 3.633

10.  Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports.

Authors:  Pierpaolo Trimboli; Massimo Bongiovanni; Fabio Rossi; Leo Guidobaldi; Anna Crescenzi; Luca Ceriani; Giuseppe Nigri; Stefano Valabrega; Francesco Romanelli; Luca Giovanella
Journal:  Endocrine       Date:  2014-10-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.